CSI Market
Sign In | Register

Panacea Life Sciences Holdings Inc (EXDI) Annual Balance Sheets

Annual · GAAP · USD millions
Access EXDI quarterly Balance Sheets →
From Panacea Life Sciences Holdings Inc through Dec 31 2019, shifts in Dec 31 2023's assets and liabilities provide insight into the company's capital structure and financial stability.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
(Dec 31 2022) (Dec 31 2021) (Dec 31 2020) (Dec 31 2019)
Assets
Cash & cash equivalent0.10
Marketable Securities, Current SH0.01
Deposits Assets AS0.00
Cash & Short-term Investments0.00
Accounts receivable0.26
Other Receivables, Net, Current0.00
Inventories4.01
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.26
Total Current Assets4.66
Equipment/Property/Plant Net6.45
Goodwill net3.01
Intangible Assets0.00
Due from Related Parties, Noncurrent LO0.00
Other Assets, Noncurrent0.00
Prepaid Expense And Other Assets Related Parties Current0.00
Operating Lease Right Of Use Asset3.86
Total Assets17.98
Liabilities
Accounts Payable and Accrued Liabilities, Current LI4.63
Accrued Liabilities, Current0.00
Derivative Liability, Current DE0.00
Notes Payable, Current NO11.40
Other Liabilities, Current3.42
Total Current Liabilities19.45
Long-term debt0.00
Convertible Notes Payable NO0.12
Total Long-term Debt0.12
Due to Other Related Parties, Noncurrent6.71
Operating Lease Liability Current2.91
Subscription Payable Current0.00
Operating Lease Liability Noncurrent3.25
Total Liabilities26.27
Stockholders' Equity
Common Stock Value0.00
Common Stock, Held by Subsidiary etc.-
Additional Paid In Capital Common Stock25.63
Retained Earnings / Accumulated Deficit-33.92
Other Equity0.00
Common Stockholder's Equity-8.29
Non-controlling interests & other0.00
Total Stockholder's Equity-8.29
Liabilities & Stockholder's Equity17.98
4 historic quarters locked

Sign in to unlock the full Panacea Life Sciences Holdings Inc balance sheet history.

Sign In Create Free Account

About Panacea Life Sciences Holdings Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20231231)
  • Filed with the SEC: April 1, 2024
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-24-012107

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.